| Post-Authorization Safety Reporting Program of Canagliflozin-based Therapy in Patients With Type 2 Diabetes in Saudi Arabia |
Ongoing |
canagliflozin |
4 |
28431754DI |
Specialized Medical Center (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), International Medical Center (Jeddah), Dallah Hospital (Riyadh), Almana Hospital (Jubail), Almouasa Hospital (Qatif), Dr. Sulaiman Al-Habib Medical Group Olaya (Riyadh), Dr. Sulaiman Al-Habib Medical Group Rayan (Riyadh), Saudi German Hospital (Jeddah) |
| AfME Registry on GastroIntestinal Stromal Tumors (GIST) – A Retrospective Patients’ Profile Description and Evaluation of the Use of Tyrosine Kinase Inhibitors |
Ongoing |
- |
4 |
WI210066 |
King Fahad Medical City (Riyadh) |
| Clinical Effectiveness and Cost Implications of Patients Switching from Oral Antipsychotics to Long‑Acting Injectable Antipsychotics in the Treatment of Schizophrenia |
Ongoing |
Consta |
4 |
RRA-19315 |
Alamal Complex for mental health (Riyadh), King Fahad University Hospital (Al-Khobar) |
| Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial |
Ongoing |
All SFDA already registered Antibiotics |
4 |
CT 15/022 |
King Abdulaziz Medical City NG (Riyadh) |
| The Impact of Tigecycline Use on Fibrinogen Level in Post Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Patients. A Randomized Controlled Study |
Ongoing |
Tigecycline |
4 |
RAC#216103 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| Forxiga (dapagliflozin) Post Authorization Safety Study |
Ongoing |
Forxiga |
4 |
D1690R0003 |
King Khalid University Hospital (Riyadh), Taibah University College of Medicine, Dr. Sulaiman Al-Habib Medical Group (Riyadh), Specialized Medical Center (Riyadh), International Medical Center (Jeddah), Dallah Hospital (Riyadh), King Abdulaziz University Hospital (Jeddah) |
| ChaRactErization of patients following aCute venous thrOmboembolism (VTE) and assessment of safety and effectiveness of dabigatran etexilate (DE) in the tReatment and secondarY prevention of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) in comparison to vitamin K antagonist (VKA) in routine clinical practice - RE-COVERY DVT/PE |
Ongoing |
Dabigatran etexilate |
4 |
1160.188 |
King Salman Bin AbdulAziz Hospital |
| "CAIN457A3404-REALIAA non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment patterns of SecukInumab and current standard of care inpatient with chronic plaque psoriAsis eligible for systemic treatment in the Asia-Pacific and Middle East regions" |
Ongoing |
Cosyntex |
4 |
IN457A3404 |
King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah) |
| A Multicenter, prospective, non-interventional study to assess Adherence to treatment for patIeNts with Relapsing Multiple Sclerosis (RMS) who are prescribed subcutaneous (sc) interferon beta-1a |
Ongoing |
Interferon Beta-1 a (Rebif) |
4 |
MS200136_0 |
King Fahad Specialist Hospital (Dammam), King Khalid University Hospital (Riyadh), King Fahad University Hospital (Al-Khobar), King Faisal Specialist Hospital and Research Center (Jeddah) |
| Real World retrospective study of effectiveness and safety of Gilenya (FINgOlimod) in relapsing remitting Multiple Sclerosis in the Middle East and North Africa (FINOMENA) |
Ongoing |
Fingolimod |
4 |
TY720DAE01 |
King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Hospital (Jeddah), King Abdulaziz Hospital Oncology Center, King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh), Al-Noor Specialist Hospital (Makkah), Hira Hospital (Makkah), King Fahad Specialist Hospital (Dammam), Dr. Erfan & Bagedo General Hospital (Jeddah) |
